Minnie Baylor-Henry
CIK: 0001747260
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (11 total)
- Jun 11, 2026APYX
Apyx Medical Corp
Award(A)DirectStock Option (Option to Buy)
50K shares- - May 14, 2026LNTH
Lantheus Holdings, Inc.
Award(A)Direct4.1K shares- - Oct 7, 2025SCPH
scPharmaceuticals Inc.
Disposition(D)DirectStock Option (Right to Buy)
12.2K shares- - Oct 7, 2025SCPH
scPharmaceuticals Inc.
Disposition(D)DirectStock Option (Right to Buy)
16.3K shares- - Oct 7, 2025SCPH
scPharmaceuticals Inc.
Disposition(D)DirectStock Option (Right to Buy)
6.1K shares- - Oct 7, 2025SCPH
scPharmaceuticals Inc.
Disposition(D)DirectStock Option (Right to Buy)
30K shares- - Oct 7, 2025SCPH
scPharmaceuticals Inc.
Disposition(D)DirectStock Option (Right to Buy)
19.8K shares- - Jun 3, 2025SCPH
scPharmaceuticals Inc.
Award(A)DirectStock Option (Right to Buy)
30K shares- - May 15, 2025APYX
Apyx Medical Corp
Award(A)DirectStock Option (Option to Buy)
59K shares- - May 14, 2025LNTH
Lantheus Holdings, Inc.
Award(A)Direct2.5K shares- - Jan 15, 2025APYX
Apyx Medical Corp
Award(A)DirectStock Option (Option to Buy)
50K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 11, 2026 |  APYX Apyx Medical Corp | Award(A) Stock Option (Option to Buy) | 50,000 | - | - | Direct |
| May 14, 2026 |  LNTH Lantheus Holdings, Inc. | Award(A) | 4,137 | - | $0 | Direct |
| Oct 7, 2025 |  SCPH scPharmaceuticals Inc. | Disposition(D) Stock Option (Right to Buy) | 12,248 | - | - | Direct |
| Oct 7, 2025 | SCPH scPharmaceuticals Inc. | Disposition(D) Stock Option (Right to Buy) | 16,300 | - | - | Direct |
| Oct 7, 2025 | SCPH scPharmaceuticals Inc. | Disposition(D) Stock Option (Right to Buy) | 6,124 | - | - | Direct |
| Oct 7, 2025 | SCPH scPharmaceuticals Inc. | Disposition(D) Stock Option (Right to Buy) | 30,000 | - | - | Direct |
| Oct 7, 2025 | SCPH scPharmaceuticals Inc. | Disposition(D) Stock Option (Right to Buy) | 19,750 | - | - | Direct |
| Jun 3, 2025 | SCPH scPharmaceuticals Inc. | Award(A) Stock Option (Right to Buy) | 30,000 | - | - | Direct |
| May 15, 2025 | APYX Apyx Medical Corp | Award(A) Stock Option (Option to Buy) | 59,000 | - | - | Direct |
| May 14, 2025 | LNTH Lantheus Holdings, Inc. | Award(A) | 2,537 | - | - | Direct |
| Jan 15, 2025 | APYX Apyx Medical Corp | Award(A) Stock Option (Option to Buy) | 50,000 | - | - | Direct |
1-11 of 11 transactions
About Baylor-Henry Minnie
Baylor-Henry Minnie (SEC CIK 0001747260) files insider reports with the SEC as Director of Apyx Medical Corp (APYX), Director of Lantheus Holdings, Inc. (LNTH) and Director of scPharmaceuticals Inc. (SCPH).
Signal8 holds 7 ownership filings by Baylor-Henry Minnie, all Form 4s, filed between Jan 17, 2025 and Jun 15, 2026. Those filings report 11 transactions, from Jan 15, 2025 to Jun 11, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Baylor-Henry Minnie's filings is in CLEARWATER, FL.
Recent filings by Baylor-Henry Minnie
- Jun 11, 2026: Grant or award of APYX derivative securities (Form 4, code A).
- May 14, 2026: Grant or award of LNTH shares (Form 4, code A).
- Oct 7, 2025: Disposition to issuer transactions of SCPH derivative securities (5 lines, Form 4, code D).
- Jun 3, 2025: Grant or award of SCPH derivative securities (Form 4, code A).
- May 15, 2025: Grant or award of APYX derivative securities (Form 4, code A).
Other insiders filing for Apyx Medical Corp (APYX)
- Waldman Lawrence, Director
- Roman Shawn David, Chief Operating Officer
- Levine Wendy Lauren, Director
- Vizirgianakis Stavros G., Director
- Goodwin Charles D. II, Chief Executive Officer
- HILL MATTHEW C, Chief Financial Officer